Bowen Acquisition Corp Files 8-K on Corporate Actions
| Field | Detail |
|---|---|
| Company | Bowen Acquisition Corp |
| Form Type | 8-K |
| Filed Date | Dec 12, 2025 |
| Risk Level | low |
| Pages | 4 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, filing-update
TL;DR
Bowen Acquisition Corp filed an 8-K on 12/12/25 detailing corporate changes and shareholder matters.
AI Summary
Bowen Acquisition Corp filed an 8-K on December 12, 2025, reporting on amendments to its articles of incorporation or bylaws, submission of matters to a vote of security holders, and financial statements and exhibits. The company, incorporated in the Cayman Islands, is involved in the SOAP, DETERGENT, CLEANING PREPARATIONS, PERFUMES, COSMETICS industry.
Why It Matters
This filing indicates corporate governance updates and potential shareholder votes for Bowen Acquisition Corp, which could impact its strategic direction and investor relations.
Risk Assessment
Risk Level: low — The filing is a routine corporate disclosure and does not appear to contain significant negative news or financial distress.
Key Players & Entities
- Bowen Acquisition Corp (company) — Registrant
- December 12, 2025 (date) — Date of earliest event reported
- Cayman Islands (jurisdiction) — State of Incorporation
- 420 Lexington Ave, Suite 2446, New York, NY 10170 (address) — Business Address
FAQ
What specific amendments were made to Bowen Acquisition Corp's articles of incorporation or bylaws?
The filing indicates that amendments were made, but the specific details of these amendments are not provided in the summary text.
What matters were submitted to a vote of security holders by Bowen Acquisition Corp?
The filing states that matters were submitted to a vote, but the nature of these matters is not detailed in the provided text.
What financial statements and exhibits are included with this 8-K filing?
The filing mentions the inclusion of financial statements and exhibits, but their specific content is not described in the provided summary.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on December 12, 2025.
What is Bowen Acquisition Corp's Standard Industrial Classification (SIC) code and industry?
Bowen Acquisition Corp's SIC code is 2840, which corresponds to the SOAP, DETERGENT, CLEANING PREPARATIONS, PERFUMES, COSMETICS industry.
Filing Stats: 1,106 words · 4 min read · ~4 pages · Grade level 15.2 · Accepted 2025-12-12 17:00:36
Key Financial Figures
- $0.0001 — Market LLC Ordinary Shares, par value $0.0001 per share BOWN The Nasdaq Stock Mar
Filing Documents
- form8-k.htm (8-K) — 61KB
- ex3-1.htm (EX-3.1) — 8KB
- 0001493152-25-027528.txt ( ) — 290KB
- bown-20251212.xsd (EX-101.SCH) — 4KB
- bown-20251212_def.xml (EX-101.DEF) — 27KB
- bown-20251212_lab.xml (EX-101.LAB) — 37KB
- bown-20251212_pre.xml (EX-101.PRE) — 25KB
- form8-k_htm.xml (XML) — 7KB
From the Filing
UNITED SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 12, 2025 BOWEN ACQUISITION CORP (Exact Name of Registrant as Specified in Charter) Cayman Islands 001-41741 N/A 00-0000000 (State or Other Jurisdiction (Commission (IRS Employer of Incorporation) File Number) Identification No.) 420 Lexington Ave , Suite 2446 New York , NY 10170 (Address of Principal Executive Offices) (Zip Code) (203) 998-5540 (Registrant's Telephone Number, Including Area Code) Not Applicable (Former Name or Former Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below): Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e 4(c)) Securities registered pursuant to section 12(b) of the Act: Title of Each Class Trading Symbol(s) Name of each exchange on which registered Units, each consisting of one ordinary share and one right BOWNU The Nasdaq Stock Market LLC Ordinary Shares, par value $0.0001 per share BOWN The Nasdaq Stock Market LLC Rights, each entitling the holder to one-tenth of one ordinary share upon the completion of the Company's initial business combination BOWNR The Nasdaq Stock Market LLC Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Item 5.03. Amendments to Articles of Incorporation or Bylaws. The information included in Item 5.07 is incorporated by reference into this item to the extent required. Item 5.07. Submission of Matters to a Vote of Security Holders. On December 12, 2025, Bowen Acquisition Corp (the "Company") held an extraordinary general meeting (the "Meeting") to approve, by special resolution and pursuant to the terms of the Company's amended and restated memorandum and articles of association, as amended (the "Articles"), an amendment to the Articles to allow the board of directors of the Company (the "Board") to extend the date (the "Extension") by which the Company must consummate an initial merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities (a "business combination"). An aggregate of 2,616,701 ordinary shares of the Company, which represented a quorum of the outstanding ordinary shares entitled to vote as of the record date of November 12, 2025, were represented in person or by proxy at the Meeting. The Company's shareholders voted on the following proposal at the Meeting, which was approved: (1) Proposal No. 1 — The Extension Proposal — a proposal to amend the Company's Articles to extend the date by which the Company has to consummate a business combination by up to three one-month increments, from December 14, 2025 to as late as June 14, 2026, unless the closing of a business combination shall have occurred prior thereto or such earlier date as shall be determined by the Board in its sole discretion. The following is a tabulation of the votes with respect to this proposal: For Against Abstain Broker Non-Votes 2,612,224 4,477 0 0 The amendments to the Amended and Restated Memorandum and Articles of Association of the Company to be filed with the Cayman Islands Registrar of Companies to effectuate the Extension are attached hereto as Exhibit 3.1. The Company is continuing to attempt to satisfy the remaining conditions to closing its proposed business combination with Shenzhen Qianzhi BioTechnology Co. Ltd. Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit Description 3.1 Amendments to Amended and Restated Memorandum and Articles of Association 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) Cautionary Note Regarding Forward Looking Statements Neither the Company nor any of its affiliates makes any representation or warranty as to the accuracy or completeness of the information contained in this Curre